Literature DB >> 24106176

Exosome encased spherical nucleic acid gold nanoparticle conjugates as potent microRNA regulation agents.

Ali H Alhasan1, Pinal C Patel, Chung Hang J Choi, Chad A Mirkin.   

Abstract

Exosomes are a class of naturally occurring nanomaterials that play crucial roles in the protection and transport of endogenous macromolecules, such as microRNA and mRNA, over long distances. Intense effort is underway to exploit the use of exosomes to deliver synthetic therapeutics. Herein, transmission electron microscopy is used to show that when spherical nucleic acid (SNA) constructs are endocytosed into PC-3 prostate cancer cells, a small fraction of them (<1%) can be naturally sorted into exosomes. The exosome-encased SNAs are secreted into the extracellular environment from which they can be isolated and selectively re-introduced into the cell type from which they were derived. In the context of anti-miR21 experiments, the exosome-encased SNAs knockdown miR-21 target by approximately 50%. Similar knockdown of miR-21 by free SNAs requires a ≈3000-fold higher concentration.
Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  cancer therapy; exosomes; gene regulation; gold nanoparticles; microRNA

Mesh:

Substances:

Year:  2013        PMID: 24106176      PMCID: PMC3947239          DOI: 10.1002/smll.201302143

Source DB:  PubMed          Journal:  Small        ISSN: 1613-6810            Impact factor:   13.281


  34 in total

1.  Nano-flares: probes for transfection and mRNA detection in living cells.

Authors:  Dwight S Seferos; David A Giljohann; Haley D Hill; Andrew E Prigodich; Chad A Mirkin
Journal:  J Am Chem Soc       Date:  2007-11-23       Impact factor: 15.419

2.  Nano-flares for mRNA regulation and detection.

Authors:  Andrew E Prigodich; Dwight S Seferos; Matthew D Massich; David A Giljohann; Brandon C Lane; Chad A Mirkin
Journal:  ACS Nano       Date:  2009-08-25       Impact factor: 15.881

3.  Selective enhancement of nucleases by polyvalent DNA-functionalized gold nanoparticles.

Authors:  Andrew E Prigodich; Ali H Alhasan; Chad A Mirkin
Journal:  J Am Chem Soc       Date:  2011-01-26       Impact factor: 15.419

4.  Oligonucleotide loading determines cellular uptake of DNA-modified gold nanoparticles.

Authors:  David A Giljohann; Dwight S Seferos; Pinal C Patel; Jill E Millstone; Nathaniel L Rosi; Chad A Mirkin
Journal:  Nano Lett       Date:  2007-11-13       Impact factor: 11.189

5.  Mesoporous Silica Nanoparticles for Cancer Therapy: Energy-Dependent Cellular Uptake and Delivery of Paclitaxel to Cancer Cells.

Authors:  Jie Lu; Monty Liong; Sean Sherman; Tian Xia; Michael Kovochich; Andre E Nel; Jeffrey I Zink; Fuyuhiko Tamanoi
Journal:  Nanobiotechnology       Date:  2007-05-01

6.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.

Authors:  Hadi Valadi; Karin Ekström; Apostolos Bossios; Margareta Sjöstrand; James J Lee; Jan O Lötvall
Journal:  Nat Cell Biol       Date:  2007-05-07       Impact factor: 28.824

7.  MicroRNA-21 targets tumor suppressor genes in invasion and metastasis.

Authors:  Shuomin Zhu; Hailong Wu; Fangting Wu; Daotai Nie; Shijie Sheng; Yin-Yuan Mo
Journal:  Cell Res       Date:  2008-03       Impact factor: 25.617

8.  The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic.

Authors:  Mark E Davis
Journal:  Mol Pharm       Date:  2009 May-Jun       Impact factor: 4.939

Review 9.  Inorganic nanosystems for therapeutic delivery: status and prospects.

Authors:  Chang Soo Kim; Gülen Yesilbag Tonga; David Solfiell; Vincent M Rotello
Journal:  Adv Drug Deliv Rev       Date:  2012-09-04       Impact factor: 15.470

10.  Regulating immune response using polyvalent nucleic acid-gold nanoparticle conjugates.

Authors:  Matthew D Massich; David A Giljohann; Dwight S Seferos; Louise E Ludlow; Curt M Horvath; Chad A Mirkin
Journal:  Mol Pharm       Date:  2009 Nov-Dec       Impact factor: 4.939

View more
  34 in total

Review 1.  DNA nanotechnology from the test tube to the cell.

Authors:  Yuan-Jyue Chen; Benjamin Groves; Richard A Muscat; Georg Seelig
Journal:  Nat Nanotechnol       Date:  2015-09       Impact factor: 39.213

2.  Research perspectives: gold nanoparticles in cancer theranostics.

Authors:  Junjie Li; Sanjay Gupta; Chun Li
Journal:  Quant Imaging Med Surg       Date:  2013-12

Review 3.  miRNA nanotherapeutics for cancer.

Authors:  Aditya Ganju; Sheema Khan; Bilal B Hafeez; Stephen W Behrman; Murali M Yallapu; Subhash C Chauhan; Meena Jaggi
Journal:  Drug Discov Today       Date:  2016-11-01       Impact factor: 7.851

4.  CMEP: a database for circulating microRNA expression profiling.

Authors:  Jian-Rong Li; Chun-Yip Tong; Tsai-Jung Sung; Ting-Yu Kang; Xianghong Jasmine Zhou; Chun-Chi Liu
Journal:  Bioinformatics       Date:  2019-09-01       Impact factor: 6.937

5.  Advances in targeted nanotherapeutics: From bioconjugation to biomimicry.

Authors:  Danielle M Valcourt; Jenna Harris; Rachel S Riley; Megan Dang; Jianxin Wang; Emily S Day
Journal:  Nano Res       Date:  2018-05-17       Impact factor: 8.897

6.  Circulating microRNA signature for the diagnosis of very high-risk prostate cancer.

Authors:  Ali H Alhasan; Alexander W Scott; Jia J Wu; Gang Feng; Joshua J Meeks; C Shad Thaxton; Chad A Mirkin
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-06       Impact factor: 11.205

Review 7.  Composite nanoparticles for gene delivery.

Authors:  Yuhua Wang; Leaf Huang
Journal:  Adv Genet       Date:  2014       Impact factor: 1.944

8.  Cellular responses of hyaluronic acid-coated chitosan nanoparticles.

Authors:  Abdulaziz Almalik; Ibrahim Alradwan; Majed A Majrashi; Bashayer A Alsaffar; Abdulmalek T Algarni; Mohammed S Alsuabeyl; Haitham Alrabiah; Nicola Tirelli; Ali H Alhasan
Journal:  Toxicol Res (Camb)       Date:  2018-05-23       Impact factor: 3.524

Review 9.  Hybrid nanoparticles for combination therapy of cancer.

Authors:  Chunbai He; Jianqin Lu; Wenbin Lin
Journal:  J Control Release       Date:  2015-09-24       Impact factor: 9.776

Review 10.  Improving the therapeutic efficiency of noncoding RNAs in cancers using targeted drug delivery systems.

Authors:  Rami Alzhrani; Hashem O Alsaab; Alex Petrovici; Ketki Bhise; Kushal Vanamala; Samaresh Sau; Matthew J Krinock; Arun K Iyer
Journal:  Drug Discov Today       Date:  2019-11-20       Impact factor: 7.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.